Literature DB >> 167182

Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood.

J Robinson.   

Abstract

Relationships between the rate of DNA synthesis in cultured human umbilical cord leukocytes and the multiplicity of added Epstein-Barr virus (EBV) were studied. At low multiplicities of approximately 0.1 transforming units/cell (approximately 10 physical particles/cell), inoculated cultures demonstrated increased rates of DNA synthesis, by comparison to uninoculated cultures, 3 days after inoculation. Stimulation of DNA synthesis was evident of progressively longer intervals after inoculations of 10-fold dilutions of virus. The rate of DNA synthesis, determined by short [-3H]thymidine pulses, reflected as small as twofold changes in multiplicity and thus can serve as a quantitative assay for the virus. Changes in the rate of DNA synthesis were evident before increases in cell number or alteration in morphology. Stimulation of DNA synthesis in umbilical cord leukocytes was inhibited by treatment of EBV with antibody and also in graded fashion, by progressive doses of UV irradiation to the virus. Induction of DNA synthesis by EBV was serum dependent. Estimates of the number of cells transformed were obtained by extrapolation from a standard curve relating known numbers of transformed cells to [-3H]thymidine incorporation and also by cloning cells after exposure to virus. At the low multiplicities of infection used in these experiments approximately 0.04 to 0.002 of the total cellular population was transformed. The high efficiency of cell transformation by EBV by comparison to other DNA tumor viruses is emphasized.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167182      PMCID: PMC354560     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS.

Authors:  I MACPHERSON; L MONTAGNIER
Journal:  Virology       Date:  1964-06       Impact factor: 3.616

2.  THE NUCLEIC ACID OF SIMIAN VIRUS 40.

Authors:  L V CRAWFORD; P H BLACK
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

3.  [A simple apparatus for determination of the ultraviolet ray output by germicidal lamps].

Authors:  R LATARJET; P MORENNE; R BERGER
Journal:  Ann Inst Pasteur (Paris)       Date:  1953-08

4.  Epstein-Barr viral antigen in single cell clones of two human leukocytic lines.

Authors:  M H Miller; D Stitt; G Miller
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

5.  Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus.

Authors:  P Gerber; B H Hoyer
Journal:  Nature       Date:  1971-05-07       Impact factor: 49.962

6.  Partial purification of the Epstein-Barr virus and some properties of its DNA.

Authors:  H Schulte-Holthausen; H zur Hausen
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

7.  Requirement for the integrity of the viral genome for the induction of host DNA synthesis by polyoma virus.

Authors:  C Basilico; G Marin; G di Mayorca
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

8.  High frequency of SV40 transformation of mouse cell line 3T3.

Authors:  G J Todaro; H Green
Journal:  Virology       Date:  1966-04       Impact factor: 3.616

9.  Susceptibility of human diploid fibroblast strains to transformation by SV40 virus.

Authors:  G J Todaro; H Green; M R Swift
Journal:  Science       Date:  1966-09-09       Impact factor: 47.728

10.  Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2.

Authors:  R Duff; F Rapp
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

View more
  24 in total

1.  CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  S Nikiforow; K Bottomly; G Miller
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus.

Authors:  J Robinson; A Frank; E Henderson; J Schweitzer; G Miller
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

3.  Effects of adenine arabinoside on lymphocytes infected with Epstein-Barr virus.

Authors:  W C Benz; P J Siegel; J Baer
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

4.  Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.

Authors:  A L Epstein; W Henle; G Henle; J F Hewetson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

5.  Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production.

Authors:  O Nyormoi; D A Thorley-Lawson; J Elkington; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

6.  Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid.

Authors:  S M Lemon; L M Hutt; J S Pagano
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

7.  Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).

Authors:  P Gergely; I Ernberg; G Klein; M Steinitz
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

8.  Radiobiological inactivation of Epstein-Barr virus.

Authors:  E Henderson; L Heston; E Grogan; G Miller
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

9.  Characterization of a lymphoblastoid line deleted for lambda immunglobulin genes.

Authors:  C A Hough; B N White; J J Holden
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists.

Authors:  G R Nemerow; N R Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.